Latest News Archive
Please select Category, Year, and then Month to display items
07 January 2018
Photo Charl Devenish
Dr Anneke van der Spoel van Dijk is invested in contributing
to the global effort of stopping TB by 2035.
The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB).
She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB).
Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.
Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”
Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”
As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.
Department of Oncology provides hyperbaric chamber to cancer patients – a first in the Free State
2016-03-21
From the left: De Villiers Brink, Gys Botes (both of the Par3 Golfday group that donated towards the hyperbaric chamber), Dr Alicia Sheriff (Head of the UFS Department of Oncology) and Prof Gert van Zyl (Dean of the UFS Faculty of Health Sciences). |
Thanks to the Department of Oncology at the University of the Free State (UFS), cancer patients now have access to a hyperbaric chamber – a medical treatment that enhances the body’s healing process through the inhalation of oxygen.
In order to realise this tremendous addition to the treatment of cancer patients, the Department of Oncology established collaboration between the UFS School of Medicine, the Free State Department of Health, and a group of private donors. Currently the only one in the Free State, the hyperbaric chamber has been installed at the Oncology ward at National Hospital in Bloemfontein and will benefit not only patients from the Free State, but also the North West province and the Northern Cape.
While lying down in the chamber, the patient’s body absorbs more oxygen as a result of the high levels of air pressure. This process stimulates the healing of cancer wounds and various other injuries, including sports injuries.
Dr Alicia Sherriff, Head of the Department of Oncology (UFS), says her team is passionate about enhancing the quality of their patients’ lives, even when facing difficult circumstances. “I believe that the hyperbaric chamber is just one way of achieving this, since it helps decrease the harm done by certain medical conditions on the human body,” Dr Sherriff says.